| | |
| | |
| Clinical data | |
|---|---|
| Trade names | Magnacort, Ulcort |
| Other names | 11β,17α-Dihydroxy-3,20-dioxopregn-4-en-21-yl N,N-diethylglycinate |
| Routes of administration | Topical |
| Pharmacokinetic data | |
| Excretion | Hepatic |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| PubChemSID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.877 |
| Chemical and physical data | |
| Formula | C27H41NO6 |
| Molar mass | 475.626 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Hydrocortamate (brand names Magnacort, Ulcortis) is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties. [1] [2] It is used topically to treat inflammation due to corticosteroid-responsive dermatoses. [3]